All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia

Blood. 1995 May 15;85(10):2643-53.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Blood Coagulation Disorders / chemically induced
  • Bone Marrow Transplantation
  • Cell Differentiation / drug effects
  • Drug Resistance
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Neoplasm, Residual / diagnosis
  • Survival Analysis
  • Thrombosis / chemically induced
  • Tretinoin / adverse effects
  • Tretinoin / therapeutic use*

Substances

  • Tretinoin